Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CREIGHTONS PLC Remuneration Information 2020

Jul 8, 2020

4734_def-14a_2020-07-08_44f74dcd-7f7e-4a51-aa20-fcb8080909be.html

Remuneration Information

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 3838S

Creightons PLC

08 July 2020

8 July 2020

Creightons PLC ("Creightons" or the "Company")

PROMOTION OF "PIPPA" CLARK TO DEPUTY MANAGING DIRECTOR

Director/PDMR Shareholdings

Creightons plc (LSE: CRL) ('Creightons" or the "Company") manufacturers of the finest quality personal care, beauty and fragrance products, is pleased to announce the promotion of Philippa ("Pippa") Clark to the position of Joint Deputy Managing Director, along-side Martin Stevens. This is part of the Company's succession planning process, and also in recognition of the significant work Ms Clark has put in over the past three months helping steer the Company's response to Covid-19.

The Company has granted a further 200,000 share options to Ms Clark, a further 100,000 share options to both Mr M Stevens and Mr P Forster and another 600,000 to other employees under the Creightons Plc Share Option Plan 2018, all at an exercise price of 36p, a discount of 19p from the market at the time of grant (the "Grant").

Since January 2009 Ms Clark has been awarded a total of 1,701,818 ordinary shares or options over ordinary shares in the Company, Mr Stevens has been awarded a total of 1,481,818 ordinary shares or options over ordinary shares in the Company and Mr Forster has been awarded a total of 1,581,818 ordinary shares or options over ordinary shares in the Company, all as part of Creighton's policy of including share- and option-based performance-related features in remuneration packages, thereby rewarding directors and managers for the Company's success.

Further to the Grant, holdings are now as described below:

Name Total number of ordinary shares held Total number of options over ordinary shares Percentage of  issued share capital
Ms P Clark, Director 651,818 1,000,000 1.54%
Mr M Stevens, Director 981,818 500,000 0.77%
Mr P Forster, Director 1,183,318 400,000 0.62%

Market Abuse Regulation

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014 ("MAR").

Contacts

Nicholas O'Shea, Creightons plc                                                                           01733 281000

Roland Cornish /Felicity Geidt, Beaumont Cornish Limited                            0207 628 3396

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail in respect of the Directors subscribing for Director Shares as described above.

Pippa Clark 

1

Details  of  the  person  discharging  managerial  responsibilities  /  person  closely associated

a)

Name

Ms P Clark

2

Reason for notification

a)

Position / status

Director

b)

Initial notification

/Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Creightons plc

b)

LEI

213800WROWAJUBGSAJ57

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description  of  the financial instrument, type of instrument

Identification code

Options over Ordinary shares of 1pence each in Creightons plc

ISIN GB0002341666

Nature of the transaction

Grant of options

Price(s) and volumes(s)

Price(s) Volumes(s)
Exercise price of 36p 200,000

d)

Aggregated information

n/a

e)

Date of the transaction

7 July 2020

f)

Place of the transaction

Off market

M Stevens 

1

Details  of  the  person  discharging  managerial  responsibilities  /  person  closely associated

a)

Name

Mr M Stevens

2

Reason for notification

a)

Position / status

Director

b)

Initial notification

/Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Creightons plc

b)

LEI

213800WROWAJUBGSAJ57

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description  of  the financial instrument, type of instrument

Identification code

Options over Ordinary shares of 1pence each in Creightons plc

ISIN GB0002341666

Nature of the transaction

Grant of Options

Price(s) and volumes(s)

Price(s) Volumes(s)
Exercise price of 36p 100,000

d)

Aggregated information

n/a

e)

Date of the transaction

7 July 2020

f)

Place of the transaction

Off market

Paul Forster 

1

Details  of  the  person  discharging  managerial  responsibilities  /  person  closely associated

a)

Name

Mr P Forster

2

Reason for notification

a)

Position / status

Director

b)

Initial notification

/Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Creightons plc

b)

LEI

213800WROWAJUBGSAJ57

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description  of  the financial instrument, type of instrument

Identification code

Options over Ordinary shares of 1pence each in Creightons plc

ISIN GB0002341666

Nature of the transaction

Grant of Options

Price(s) and volumes(s)

Price(s) Volumes(s)
Exercise price of 36p 100,000

d)

Aggregated information

n/a

e)

Date of the transaction

7 July 2020

f)

Place of the transaction

Off market

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHKZGGNNRKGGZG